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Editors: Anton N. Sidawy and Bruce A. PerlerEndovascular repair compared with surveillance for patients with small
abdominal aortic aneurysms
Kenneth Ouriel, Daniel G. Clair, K. Craig Kent, Christopher K. Zarins, Positive
Impact of Endovascular Options for treating Aneurysms Early (PIVOTAL)
Investigators
Background: Although repair of large abdominal aortic aneurysms (AAAs) is
well accepted, randomized clinical trials have failed to demonstrate benefit
for early surgical repair of small aneurysms compared with surveillance.
Endovascular repair has been shown to be safer than open surgical repair
in patients with large aneurysms, prompting a randomized trial of early
endovascular repair vs surveillance in patients with small aneurysms.
Methods: We randomly assigned 728 patients (13.3% women; mean age, 71
 8 years) with 4 to 5 cm AAAs to early endovascular repair (366 patients)
or ultrasound surveillance (362 patients). Rupture or aneurysm-related
death and overall mortality in the two groups were compared during a mean
follow-up of 20  12 months.
Results: Among patients randomized to treatment, 89% underwent aneu-
rysm repair. Among patients randomized to surveillance, 31% underwent
aneurysm repair during the course of the study. After a mean follow-up of
20  12 months (range, 0-41 months), 15 deaths had occurred in each group
(4.1%). The unadjusted hazard ratio (95% confidence interval) for mortality
after early endovascular repair was 1.01 (0.49-2.07, P = .98). Aneurysm
rupture or aneurysm-related death occurred in two patients in each group
(0.6%). The unadjusted hazard ratio was 0.99 (0.14-7.06, P = .99) for early
endovascular repair.
Conclusions: Early treatment with endovascular repair and rigorous surveil-
lance with selective aneurysm treatment as indicated both appear to be safe
alternatives for patients with small AAAs, protecting the patient from
rupture or aneurysm-related death for at least 3 years.Defining high risk in endovascular aneurysm repair
Tara M. Mastracci, Roy K. Greenberg, Adrian V. Hernandez, Catherine
Morales
Background: Long-term survival benefit contrasted with rupture risk should
determine which patients are suitable for abdominal aortic aneurysm (AAA)
intervention. Our aim was to develop a model capable of predicting long-
term survival based on preoperative characteristics.
Methods: A prospective cohort study using Cox regression modeling. We
aimed to associate preoperative characteristics with long-term mortality,
and create a predictive nomogram, which was then externally validated
on an independent cohort (697 patients) who underwent endovascular
abdominal aortic aneurysm (AAA) repair.
Results: We pooled the results of 412 patients undergoing endovascular
repair of infrarenal and juxtarenal aneurysm who were high risk (average* Full articles available online at www.jvascsurg.org
1078e5884/$36.00
doi:10.1016/S1078-5884(10)00250-9Glasgow aneurysm scores of 72.8 [SD 10.4]). Despite anatomic differences,
there were no statistically significant differences in perioperative or long-
term outcomes between infrarenal and juxtarenal aneurysms (log rank test,
P = .5). Data from this group (64% infrarenal aneurysms and 36% juxtarenal
aneurysms) were randomly and evenly split into a model development and
test group. Independent predictors of mortality included in the model are
age, aneurysm diameter, history of peripheral artery disease, chronic
obstructive pulmonary disease (COPD), or congestive heart failure, require-
ment for supplemental home oxygen, and use of salicylates. Internal valida-
tion reveals good calibration and discriminative ability (c-statistic 0.68 [95%
confidence interval 0.65-0.71]). External validation confirms good
calibration.
Conclusions: In the context of acceptable perioperative results, long-term
mortality risk can be predicted in endovascular AAA repair and must be
balanced against risk of rupture to determine which patients should be
offered treatment.Prospective randomized trial of routine versus selective shunting in
carotid endarterectomy based on stump pressure
Ali F. AbuRahma, Patrick A. Stone, Stephen M. Hass, L. Scott Dean, Joseph
Habib, Tammi Keiffer, Mary Emmett
Background: The use of shunting in carotid endarterectomy (CEA) is contro-
versial. This randomized trial compared the results of routine (RS) vs selec-
tive shunting (SS) based on stump pressure (SP).
Methods: Two-hundred CEA patients under general anesthesia were
randomized into RS (98 patients) or SS (102 patients), where shunting was
used only if systolic SP (SSP) was <40 mm Hg. Clinical and demographic char-
acteristics were comparable in both groups. Patients underwent immediate
and 30-day postoperative duplex ultrasound follow-up. Analysis was by
intention-to-treat.
Results: Of 102 SS patients, 29 (28%) received shunting. Indications for CEA
were similar (42% symptomatic for RS; 47% for SS, P = .458). The mean
internal carotid artery diameter was comparable (5.5 vs 5.5 mm, P = .685).
Mean preoperative ipsilateral and contralateral stenosis was 76% and 38%
for RS (P = .268) vs 78% and 40% for SS (P = .528). Mean preoperative ipsilat-
eral and contralateral stenosis was 79% and 56% in the shunted (P = .634) vs
78% and 34% in the nonshunted subgroup of SS patients (P = .002). The mean
SSP was 55.9 mm Hg in RS vs 56.2 for SS (P = .915). The mean SSP was 33 mm
Hg in the shunted vs 65 in the nonshunted subgroup (P < .0001). Mean clamp
time in the nonshunted subgroup of SS was 32 minutes. Mean shunt time was
35 minutes in RS and 33 in SS (P = .354). Mean operative time was 113
minutes for RS and 109 for SS (P = .252), and 111 minutes in shunted and
108 in the nonshunted subgroup (P = .586). Mean arteriotomy length was
4.4 cm for RS and 4.2 for SS (P = .213). Perioperative stroke rate was 0%
for RS vs 2% for SS (one major and one minor stroke, both related to carotid
thrombosis; P = .498). No patients died perioperatively. Combined perio-
perative transient ischemic attack (TIA) and stroke rates were 2% in RS vs
2.9% in SS (P > .99). The overall perioperative complication rates were
8.3% in RS (2 TIA, 3 hemorrhage, 1 myocardial infarction [MI], and 1
Abstracts 657asymptomatic carotid thrombosis) vs 7.8% in SS (2 strokes, 1 TIA, 3 hemor-
rhage, 1 MI, and 1 congestive heart failure; P = .917).
Conclusions: RS and SS were associated with a low stroke rate. Both
methods are acceptable, and surgeons should select the method with which
they are more comfortable.Sustained cognitive benefit 5 years after carotid endarterectomy
Martin Czerny, Philipp Schuch, Gottfried Sodeck, Csilla Balassy, Thomas
Hoelzenbein, Andrzej Juraszek, Tomasz Dziodzio, Michael Grimm
Objectives: This study investigated the long-term effect of carotid endar-
terectomy (CEA) on cognitive brain function by means of P300 evoked
potentials.
Methods: Twenty-five consecutive patients (36% women) with a median age
of 68 years underwent CEA with a median degree of stenosis of 90%. Cogni-
tive brain function was objectively measured by means of P300 auditory
evoked potentials (peak latencies in milliseconds [ms]) before CEA, at
discharge, and at 1 and 5 years. Values were compared with 25 age- and
sex-matched healthy individuals.
Results: Cognitive P300 evoked potentials were prolonged (ie, impaired) in
patients before CEA compared with controls (vertex [Cz], 384  52 vs 357 
16 ms, P = .020]. At 1 year, P300 evoked potentials were significantly short-
ened (ie, improved) in patients after CEA compared with baseline values [Cz,
371  38 vs 384  52 ms, P = .010]. Furthermore, no difference between
patients after CEA and controls was observed [Cz, 371  38 vs 360  14
ms, P = .21]. This effect was sustained at 5 years, and P300 evoked poten-
tials continued to be significantly shortened (ie, improved) in patients after
CEA compared with baseline values [Cz, 367  39 vs 384  52 ms, P = .040].
Continuing, no difference between patients after CEA and controls could be
observed [Cz, 367  39 vs 362  17 ms, P = .58]. These results could be
confirmed in repeated measures analysis of variance for Cz (P = .025) and
frontal (Fz) results (P = .018).
Conclusions: CEA improves previously impaired cognitive brain function as
shown by P300 measurements similar to normal cognitive brain function of
age- and sex-matched healthy individuals. This beneficial effect is sustained
up to 5 years after treatment.Insulin use is associated with poor limb salvage and survival in diabetic
patients with chronic limb ischemia
Hasan H. Dosluoglu, Purandath Lall, Nader D. Nader, Linda M. Harris, Maciej
L. Dryjski
Objective: The goal was to compare the outcomes in patients with disabling
claudication (DC) or critical limb ischemia (CLI) to determine if diabetics
(DM) have poorer patency, limb salvage (LS), and survival rates than nondi-
abetic patients and if the diabetic regimen affects these outcomes.
Methods: All patients who presented with DC or CLI between June 2001 and
September 2008 were included. Non-DM patients were compared with those
with DM who are currently managed by diet only or oral medications (D-OM),
oral medications plus insulin (OM+INS), or insulin alone (INS).
Results: Of the 746 patients (886 limbs), there were 406 patients (464 limbs)
in non-DM, 96 patients (135 limbs) in D-OM, 98 patients (118 limbs) in OM
+INS, and 146 patients (185 limbs) in INS groups. There were more patients
with coronary artery disease, hypertension, and renal insufficiency in the
DM group than non-DM, with the INS group having the highest incidence of
renal insufficiency/dialysis (46%/20%). Gangrene and foot sepsis were signif-
icantly more frequent in patients in OM+INS (45%/3%) and INS (50%/6%) than
non-DM (15%/0.2%) and D-OM groups (25%/1%; P < .001). More patients in the
INS group (14%) and OM+INS (9%) had primary amputation than non-DM (4%)
and D-OM (4%; P < .01). Mean follow-up was 26.3  20.7 months. Overall
survival following revascularization was similar in D-OM and non-DM and
OM+INS and INS, the latter being significantly worse (P < .001). The LS rate
in D-OM and non-DM was also identical, whereas OM-INS and INS had signif-
icantly worse LS, with OM-INS marginally better than INS (P = .094). Primary
patency (PP) was worse in endovascular-treated patients on insulin than
non-DM and D-OM patients (P < .001), whereas PP was similar between
groups in open-treated patients. Multivariate analysis showed that coronary
artery disease, renal insufficiency, chronic obstructive pulmonary disease,indication for intervention, insulin use, nonambulatory status, and statin
drug non-use were independently associated with decreased survival,
whereas insulin use, presence of gangrene, need for infrapopliteal interven-
tions, and nonambulatory status were independently associated with limb
loss. TransAtlantic Inter-Society Consensus (TASC) classification of the
treated lesions being C or D, infrapopliteal interventions, and indication of
intervention (DC vs CLI) were independently associated with primary
patency, whereas insulin use was not.
Conclusions: Diabetic patients who present with limb ischemia can be sub-
divided into three distinct subgroups based on their diabetic regimen. The
survival and LS rates of those controlled with diet or OM are nearly identical
to nondiabetics, both of which are significantly better than OM+INS or INS.
The PP rate in endovascular-treated patients is worse in patients who are
on insulin. Being on insulin is independently associated with decreased
survival and limb loss but not PP.Quality of life before surgery is a predictive factor for satisfaction among
patients undergoing sympathectomy to treat hyperhidrosis
Nelson Wolosker, Guilherme Yazbek, Jose´ Ribas Milanez de Campos, Marco
Antonio Munia, Paulo Kauffman, Fabio Biscegli Jatene, Pedro Puech-Leao
Purpose: The objective of this study was to evaluate the postoperative
quality of life (QOL) experienced among a group of 1167 patients who under-
went video-assisted thoracoscopic sympathectomy (VATS) to treat primary
hyperhidrosis, as compared with the presurgical QOL.
Methods: Between February 2002 and June 2007, 1167 patients who had
undergone VATS were surveyed. The majority had presented with palmar
hyperhidrosis (794 patients; 68%), while 340 (29%) had presented with axil-
lary hyperhidrosis. Based on data obtained from the QOL protocol applied
to all of the patients preoperatively, the patients were divided into two
groups according to the level of their QOL: group 1 consisted of 312 patients
(27%) with poor QOL and group 2 of 855 patients (73%) with very poor QOL.
The same protocol was applied postoperatively, and five different levels of
satisfaction were obtained. The same parameters were evaluated for both
the palmar and the axillary hyperhidrosis subgroups.
Results: The patients with very poor QOL had much better results in terms
of improvement in QOL than did those with poor QOL (P < .05). The same
result was observed for both the palmar and axillary hyperhidrosis subgroups
(P < .05).
Conclusion: The worse the preoperative QOL among patients undergoing
sympathectomy to treat primary hyperhidrosis is, the better the postopera-
tive improvement in QOL will be.Renal parenchymal preservation after percutaneous renal angioplasty
and stenting
Mark G. Davies, Wael E. Saad, Jean Bismuth, Joseph J. Naoum, Eric K. Peden,
Alan B. Lumsden
Background: The intent of endovascular therapy for symptomatic athero-
sclerotic renal artery stenosis (ARAS) is to preserve parenchyma and avoid
renal-related morbidity. The aim of this study is to examine the impact of
renal artery intervention on parenchymal preservation.
Methods: We performed a retrospective analysis of records from patients
who underwent endovascular intervention for ARAS and were followed by
duplex ultrasound between 1990 and 2008. Renal volume (in cm3) was esti-
mated in all patients as renal length (cm)  renal width (cm)  renal depth
(cm)  0.5. The normal renal volume was calculated as 2  body weight (kg)
in cm3. Failure of preservation was considered to be a persistent 10%
decrease in volume. Clinical benefit defined as freedom from renal-related
morbidity (increase in persistent creatinine >20% of baseline, progression
to hemodialysis, death from renal-related causes) was calculated.
Results: Five hundred ninety-two renal artery interventions were per-
formed. One hundred eighty-six kidneys suffered parenchymal loss (>5%)
with an actuarial parenchymal loss rate of 29%  1% at five years respec-
tively. There were no significant differences in age, gender, starting renal
volume, or kidney size. However, patients with parenchymal loss had lower
eGFR (45  24 vs 53  24 mL/min/1.73 m2; Loss vs noLoss, P = .0002, Mean 
SD) higher resistive index (0.75  0.9 vs 0.73  0.10; P = .0001) and worse
658 Abstractsnephrosclerosis grade (1.43  0.55 vs 1.30  0.49; P = .006) then those
not suffering parenchymal loss. Parenchymal loss was associated with
significantly worse five-year survival (26%  4% vs 48%  2%; Loss vs
noLoss; P < .001) and freedom from renal-related morbidity (70%  5%
vs 82%  2%; P < .05) with increased numbers progressing to dialysis (17%
vs 7%; P < .006).
Conclusion: While parenchymal preservation occurs in most patients, paren-
chymal loss occurs in 31% of patients and is associated with markers of
impaired parenchymal perfusion (resistive index and nephrosclerosis grade)
at the time of intervention. Pre-existing renal size or volumes were not
predictive of parenchymal loss. Parenchymal loss is associated with a signif-
icant decrease in survival and a marked increased renal related morbidity
and progression to hemodialysis.Electronic medical records for the office
Ronald A. Bays, L. Dan Kaelin
Electronic medical records are gathering significant attention with the
recent State and Federal initiatives, Medicare Physician Quality Reporting
Initiatives (PQRI), and stimulus funds. The conversion to an electronic envi-
ronment from the comfortable but inefficient paper record can be
confusing, difficult, and costly if the practice does not complete the proper
analysis and planning for the transformation. Significant monetary assistance
is available for practices during this process, with resultant increased prac-
tice efficiency and patient safety. To be successful, the practice must fully
understand the expected benefits and must evaluate each of the options to
be sure the entire practice workflow is considered.
